John Paulson’s portfolio: Paulson & Co 13F holdings

Quarterly SEC 13F-HR filingsCIK 0001035674Latest: Q2 2026

Q2 2017 filing in brief

In its Q2 2017 13F, filed August 14, 2017, Paulson & Co reported $7.4B across 109 US positions. The largest: ALLERGAN PLC (8.9%), MYLAN N V (8.4%), SHIRE PLC (7.8%), GLD (7.0%), VALEANT PHARMACEUTICALS INTL (5.1%). In the quarter it opened 30 positions, sold out of 19, added to 18 and trimmed 35; positions opened and sold out came to 14.9% of the portfolio's value.

Methodology

Holdings come from the manager’s Form 13F-HR filings on SEC EDGAR, with amendments applied. Values and shares are reported at quarter-end; the filing date is when the report became public. These disclosures show reported long positions and listed options, not the manager’s entire portfolio or its trades since quarter-end.

Quarterly changes compare shares with the immediately preceding quarter on file. New and exited positions appear or disappear; added and trimmed positions change their share count by more than 1%. A share change can also reflect a stock split or other corporate action.

Opened and sold out is the value of new positions plus the prior value of exited positions, divided by the average of the two quarters’ reported portfolio values. It excludes changes to positions still held. Reported value growth includes price changes and is not a measure of investment performance. Largest-five and largest-ten weights exclude options.

Holdings

Filed Aug 14, 2017

  • 30 New
  • 18 Added
  • 35 Trimmed
  • 19 Exited

109 positions at June 30, 2017. Q/Q change compares shares with the preceding quarter.

RowTickerIssuerStatus
1—ALLERGAN PLC$657M2.7M8.89%−8.1%Trimmed
2—MYLAN N V$619M15.9M8.36%−7.8%Trimmed
3—SHIRE PLC$575M3.5M7.78%−12.9%Trimmed
4GLDSPDR GOLD TRUST$515M4.4M6.96%0.0%Held
5—VALEANT PHARMACEUTICALS INTL$377M21.8M5.10%+12.5%Added
6TMUST MOBILE US INC$367M6.1M4.96%+46.1%Added
7—MALLINCKRODT PUB LTD CO$309M6.9M4.17%−8.1%Trimmed
8TWXCHFTIME WARNER INC$300M3.0M4.05%−1.2%Trimmed
9AIGAMERICAN INTL GROUP INC$259M4.1M3.50%−9.0%Trimmed
10DISHDISH NETWORK CORP$251M4.0M3.39%+15.9%Added
11—CAESARS ACQUISITION CO$250M13.1M3.38%0.0%Held
12TEVATEVA PHARMACEUTICAL INDS LTD$224M6.7M3.03%−38.7%Trimmed
13VSTVISTRA ENERGY CORP$194M11.5M2.62%—New
14CZRCAESARS ENTMT CORP$173M14.4M2.34%0.0%Held
15AABAUSDALTABA INC$146M2.7M1.97%—New
16—NXP SEMICONDUCTORS N V$131M1.2M1.78%+6.0%Added
17—REALOGY HLDGS CORP$130M4.0M1.75%−16.4%Trimmed
18AU3EURANGLOGOLD ASHANTI LTD$124M12.8M1.68%0.0%Held
19—SYNERGY PHARMACEUTICALS DEL$107M24.1M1.45%0.0%Held
20NGNOVAGOLD RES INC$100M22.0M1.36%−0.6%Held
21—VWR CORP$88M2.7M1.19%—New
22TSUTIM PARTICIPACOES S A$82M5.6M1.11%−1.1%Trimmed
23WLHUSDLYON WILLIAM HOMES$80M3.3M1.08%0.0%Held
24—ENDO INTL PLC$80M7.2M1.08%−8.5%Trimmed
25—BANK AMER CORP$75M6.3M1.02%0.0%Held
26—INTERNATIONAL SEAWAYS INC$75M3.5M1.01%−5.9%Trimmed
27BKDBROOKDALE SR LIVING INC$73M5.0M0.99%−1.1%Trimmed
28ODPEUROFFICE DEPOT INC$71M12.6M0.96%−11.6%Trimmed
29—HORIZON PHARMA PLC$59M4.9M0.79%—New
30—LOXO ONCOLOGY INC$55M686.9K0.74%−15.5%Trimmed
31CIEI 3.125 05/15/24COBALT INTL ENERGY INC$44M219.2M0.59%0.0%Held
32OASEUROASIS PETE INC NEW$39M4.9M0.53%−5.6%Trimmed
33—RANDGOLD RES LTD$38M431.7K0.52%0.0%Held
34STAYUSDEXTENDED STAY AMER INC$35M1.8M0.47%−91.0%Trimmed
35AEMAGNICO EAGLE MINES LTD$34M757.6K0.46%0.0%Held
36—ENZYMOTEC LTD$34M4.2M0.46%0.0%Held
37HTZ-WEURHERTZ GLOBAL HLDGS INCput option$29M2.5M0.40%—New
38THMINTERNATIONAL TOWER HILL MIN$27M55.5M0.36%0.0%Held
39—XCERRA CORP$25M2.5M0.33%—New
40ALXNALEXION PHARMACEUTICALS INCcall option$24M200.0K0.33%0.0%Held
41METAFACEBOOK INC$22M144.5K0.29%−22.0%Trimmed
42—SHIRE PLCcall option$21M125.0K0.28%−3.8%Trimmed
43ARNCCHFARCONIC INC$20M897.5K0.27%−8.7%Trimmed
44IAGIAMGOLD CORP$20M3.9M0.27%0.0%Held
45—MONSANTO CO NEW$19M159.2K0.25%+348.5%Added
46—MOBILEYE N V AMSTELVEEN$17M272.6K0.23%+258.7%Added
47FDXFEDEX CORP$16M75.4K0.22%+52.3%Added
48XENTEURINTERSECT ENT INC$16M558.0K0.21%−12.8%Trimmed
49—REYNOLDS AMERICAN INC$15M236.8K0.21%+87.9%Added
50NEWREURNEW RELIC INC$15M353.3K0.21%—New
51—ATLASSIAN CORP PLC$14M397.9K0.19%+152.8%Added
52DOVADOVA PHARMACEUTICALS INC$14M621.6K0.19%—New
53DXCMDEXCOM INC$13M183.4K0.18%−23.8%Trimmed
54BCRUSDBARD C R INC$13M42.1K0.18%—New
55TIME1EURTIME INC NEW$13M887.2K0.17%−9.6%Trimmed
56ALXNALEXION PHARMACEUTICALS INC$13M103.2K0.17%−69.1%Trimmed
57—GLAXOSMITHKLINE PLC$12M289.5K0.17%−30.3%Trimmed
58SDSANDRIDGE ENERGY INC$11M666.5K0.16%0.0%Held
59TGNATEGNA INC$11M778.3K0.15%—New
60PANWPALO ALTO NETWORKS INC$11M80.1K0.14%−48.6%Trimmed
61—STERIS PLC$11M131.5K0.14%−68.9%Trimmed
62SNAPSNAP INCput option$10M580.0K0.14%0.0%Held
63—ESPERION THERAPEUTICS INC NE$10M210.5K0.13%−9.2%Trimmed
64ISRGINTUITIVE SURGICAL INC$10M10.2K0.13%+37.8%Added
65CTRPUSDCTRIP COM INTL LTD$9M173.2K0.13%—New
66—SPECTRANETICS CORP$9M237.5K0.12%—New
67HCAHCA HEALTHCARE INC$8M90.0K0.11%—New
68ZZILLOW GROUP INC$8M160.0K0.11%−3.9%Trimmed
69—MYLAN N Vcall option$8M200.0K0.10%0.0%Held
70SASEABRIDGE GOLD INC$8M700.0K0.10%—New
71AMZNAMAZON COM INC$8M7.8K0.10%+41.8%Added
72MGIEURMONEYGRAM INTL INC$8M435.9K0.10%—New
73TMQTRILOGY METALS INC NEW$7M11.6M0.10%−0.2%Held
74—BANK AMER CORP$7M8.9M0.10%0.0%Held
75SERVSERVICEMASTER GLOBAL HLDGS I$7M174.0K0.09%+52.6%Added
76—ALBANY MOLECULAR RESH INC$7M314.2K0.09%—New
77—SYNTHESIS ENERGY SYS INC$7M10.0M0.09%0.0%Held
78DVAXDYNAVAX TECHNOLOGIES CORP$5M554.6K0.07%+19.8%Added
79COR1EURCORESITE RLTY CORP$5M49.0K0.07%−18.6%Trimmed
80CIE1EURCOBALT INTL ENERGY INC$5M2.0M0.07%—New
81MELIMERCADOLIBRE INC$5M20.0K0.07%−27.0%Trimmed
82—KAMADA LTD$5M790.8K0.06%+8.2%Added
83GRFSGRIFOLS S A$4M196.8K0.06%—New
84—WEBMD HEALTH CORP$4M64.7K0.05%−55.5%Trimmed
85WDAYWORKDAY INC$4M38.6K0.05%—New
86GOOGALPHABET INC$4M4.0K0.05%−64.3%Trimmed
87CYHCOMMUNITY HEALTH SYS INC NEWput option$3M340.0K0.05%0.0%Held
882655787DBLUEPRINT MEDICINES CORP$3M65.8K0.05%—New
89—K2M GROUP HLDGS INC$3M109.6K0.04%+13.6%Added
90SNYSANOFI$2M52.0K0.03%−65.3%Trimmed
91PBYIPUMA BIOTECHNOLOGY INC$2M27.5K0.03%+75.3%Added
92BCRXBIOCRYST PHARMACEUTICALS$2M349.5K0.03%—New
93RIGLRIGEL PHARMACEUTICALS INC$2M662.1K0.02%+20.4%Added
94AAPLAPPLE INC$2M12.3K0.02%—New
95—ENTELLUS MED INC$2M102.7K0.02%—New
96IMGNEURIMMUNOGEN INC$2M229.2K0.02%—New
97HALOHALOZYME THERAPEUTICS INC$1M111.1K0.02%—New
98PODDINSULET CORP$1M25.0K0.02%—New
99—IGNYTA INC$1M123.0K0.02%—New
100MULEUSDMULESOFT INC$1M43.0K0.01%+115.0%Added
101—TREVENA INC$938K407.6K0.01%0.0%Held
102EDITEDITAS MEDICINE INC$839K50.0K0.01%0.0%Held
103NTLAINTELLIA THERAPEUTICS INC$778K48.6K0.01%−38.2%Trimmed
104SIENUSDSIENTRA INC$776K79.8K0.01%—New
105—CRISPR THERAPEUTICS AG$457K28.5K0.01%−43.6%Trimmed
106—TANDEM DIABETES CARE INC$400K500.0K0.01%0.0%Held
107HUNHUNTSMAN CORP$336K13.0K0.00%—New
108ARDMEURARADIGM CORP$252K192.7K0.00%0.0%Held
109OKTAOKTA INC$171K7.5K0.00%—New
19 exited positions

Positions held in the preceding quarter and absent from this filing. Values and shares are from the preceding quarter.

TickerIssuerPrevious valuePrevious shares
AKRXEURAKORN INC$202M8.4M
—MEAD JOHNSON NUTRITION CO$105M1.2M
—WHITEWAVE FOODS CO$38M670.0K
—COBALT INTL ENERGY INC$17M30.9M
EBAYEBAY INC$16M471.2K
PFEPFIZER INC$14M407.5K
—FIDELITY & GTY LIFE$11M400.0K
ETSYETSY INC$9M833.0K
—NEUSTAR INC$7M200.0K
BIIBBIOGEN INC$5M17.3K
—NOVADAQ TECHNOLOGIES INCput option$4M500.0K
BCRXBIOCRYST PHARMACEUTICALScall option$3M350.0K
—HEADWATERS INC$2M100.0K
SRPTSAREPTA THERAPEUTICS INC$2M78.1K
INSMINSMED INC$2M90.0K
ALDR1EURALDER BIOPHARMACEUTICALS INC$2M74.0K
CNCEEURCONCERT PHARMACEUTICALS INC$1M70.2K
OSG1EUROVERSEAS SHIPHOLDING GROUP I$174K45.1K
ARCCARES CAP CORP$01
Every quarter on file (53)

From the manager’s Form 13F-HR filings on SEC EDGAR, amendments applied. Long US positions only; not a recommendation.